Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation.
Saved in:
| Title: | Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation. |
|---|---|
| Authors: | TeBay C; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia., McArthur JR; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia., Mangala M; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia., Kerr N; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia., Heitmann S; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia., Perry MD; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; School of Medical Sciences, UNSW Sydney, Sydney, New South Wales, Australia., Windley MJ; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia., Vandenberg JI; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia., Hill AP; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia. |
| Source: | British journal of pharmacology [Br J Pharmacol] 2022 Jun; Vol. 179 (11), pp. 2631-2646. Date of Electronic Publication: 2022 Jan 27. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34837219 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22TeBay+C%22">TeBay C</searchLink>; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22McArthur+JR%22">McArthur JR</searchLink>; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Mangala+M%22">Mangala M</searchLink>; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Kerr+N%22">Kerr N</searchLink>; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Heitmann+S%22">Heitmann S</searchLink>; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Perry+MD%22">Perry MD</searchLink>; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; School of Medical Sciences, UNSW Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Windley+MJ%22">Windley MJ</searchLink>; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Vandenberg+JI%22">Vandenberg JI</searchLink>; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Hill+AP%22">Hill AP</searchLink>; Molecular Cardiology and Biophysics, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227502536%22">British journal of pharmacology</searchLink> [Br J Pharmacol] 2022 Jun; Vol. 179 (11), pp. 2631-2646. <i>Date of Electronic Publication: </i>2022 Jan 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7502536 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5381 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071188%22">00071188 </searchLink><i>NLM ISO Abbreviation: </i>Br J Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34837219 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bph.15757 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2631 Titles: – TitleFull: Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: TeBay C – PersonEntity: Name: NameFull: McArthur JR – PersonEntity: Name: NameFull: Mangala M – PersonEntity: Name: NameFull: Kerr N – PersonEntity: Name: NameFull: Heitmann S – PersonEntity: Name: NameFull: Perry MD – PersonEntity: Name: NameFull: Windley MJ – PersonEntity: Name: NameFull: Vandenberg JI – PersonEntity: Name: NameFull: Hill AP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2022 Jun Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1476-5381 Numbering: – Type: volume Value: 179 – Type: issue Value: 11 Titles: – TitleFull: British journal of pharmacology Type: main |
| ResultId | 1 |